Response: Granulocyte/macrophage colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy persons
- PMID: 20075172
- PMCID: PMC2808163
- DOI: 10.1182/blood-2009-11-246041
Response: Granulocyte/macrophage colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy persons
Comment on
-
Activated cryptic granulocyte-macrophage colony-stimulating factor autoantibodies in intravenous immunoglobulin preparations.Blood. 2010 Jan 14;115(2):431. doi: 10.1182/blood-2009-08-240309. Blood. 2010. PMID: 20075173 No abstract available.
References
-
- St-Amour I, Laroch A, Bazin R, Lemieux R. Activation of cryptic IgG reactive with BAFF, amyloid beta peptide adn GM-CSF during the industrial fractionation of human plasma into therapeutic intravenous immunoglobulins. Clin Immunol. 2009;133(1):52–60. - PubMed
-
- Bouvet J, Stahl D, Rose S, Auan C, Kazatchkine M, Kaveri S. Induction of natural autoantibody activity following treatment of human immunoglobulin with dissociating agents. J Autoimmun. 2001;16(2):163–1172. - PubMed
-
- Uchida K, Nakata K, Trapnell BC, et al. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. Blood. 2004;103(3):1089–1098. - PubMed
-
- Watanabe M, Uchida K, Nakagaki K, et al. Anti-cytokine autoantibodies are ubiquitous in healthy individuals. FEBS Lett. 2007;581(10):2017–2021. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases